Page last updated: 2024-09-05

ak 295 and Cognition Disorders

ak 295 has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartus, RT; Hayward, NJ; McIntosh, TK; Murai, H; Perri, BR; Saatman, KE; Smith, DH	1

Other Studies

1 other study(ies) available for ak 295 and Cognition Disorders

Article	Year
Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-16, Volume: 93, Issue:8 Topics: Animals; Brain Injuries; Calpain; Cognition Disorders; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Male; Memory; Psychomotor Performance; Rats; Rats, Sprague-Dawley	1996

Article

Year

Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat.

Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-16, Volume: 93, Issue:8

Topics: Animals; Brain Injuries; Calpain; Cognition Disorders; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Male; Memory; Psychomotor Performance; Rats; Rats, Sprague-Dawley

1996